MEDPACE HOLDINGS INC (MEDP) Stock Overview
USA - NASDAQ:MEDP - US58506Q1094 - Common Stock
MEDP Key Statistics, Chart & Performance
The current stock price of MEDP is 490.64 USD. In the past month the price increased by 6.97%. In the past year, price increased by 39.52%.
MEDP Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 21.9 | 181.05B | ||
| DHR | DANAHER CORP | 25.24 | 136.09B | ||
| A | AGILENT TECHNOLOGIES INC | 22.61 | 34.94B | ||
| IQV | IQVIA HOLDINGS INC | 16.32 | 31.83B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 30.8 | 25.95B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 36.42 | 18.23B | ||
| WAT | WATERS CORP | 24.15 | 17.58B | ||
| TEM | TEMPUS AI INC | N/A | 15.01B | ||
| ILMN | ILLUMINA INC | 22.87 | 14.62B | ||
| ICLR | ICON PLC | 13.23 | 13.61B | ||
| QGEN | QIAGEN N.V. | 19.27 | 9.82B | ||
| RVTY | REVVITY INC | 16.95 | 9.62B |
Related stock screener links
About MEDP
Company Profile
Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company is headquartered in Cincinnati, Ohio and currently employs 6,000 full-time employees. The company went IPO on 2016-08-11. The firm partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company’s drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The firm also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company’s operations are principally based in North America, Europe, and Asia.
Company Info
MEDPACE HOLDINGS INC
5375 Medpace Way
Cincinnati OHIO 45227 US
CEO: August J. Troendle
Employees: 5900
Phone: 15135799911
MEDPACE HOLDINGS INC / MEDP FAQ
What is the stock price of MEDPACE HOLDINGS INC today?
The current stock price of MEDP is 490.64 USD. The price decreased by -1.4% in the last trading session.
What is the ticker symbol for MEDPACE HOLDINGS INC stock?
The exchange symbol of MEDPACE HOLDINGS INC is MEDP and it is listed on the Nasdaq exchange.
On which exchange is MEDP stock listed?
MEDP stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for MEDPACE HOLDINGS INC stock?
17 analysts have analysed MEDP and the average price target is 433.33 USD. This implies a price decrease of -11.68% is expected in the next year compared to the current price of 490.64. Check the MEDPACE HOLDINGS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is MEDPACE HOLDINGS INC worth?
MEDPACE HOLDINGS INC (MEDP) has a market capitalization of 13.78B USD. This makes MEDP a Large Cap stock.
How many employees does MEDPACE HOLDINGS INC have?
MEDPACE HOLDINGS INC (MEDP) currently has 5900 employees.
What are the support and resistance levels for MEDPACE HOLDINGS INC (MEDP) stock?
MEDPACE HOLDINGS INC (MEDP) has a support level at 485.75. Check the full technical report for a detailed analysis of MEDP support and resistance levels.
Is MEDPACE HOLDINGS INC (MEDP) expected to grow?
The Revenue of MEDPACE HOLDINGS INC (MEDP) is expected to grow by 16.85% in the next year. Check the estimates tab for more information on the MEDP EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy MEDPACE HOLDINGS INC (MEDP) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of MEDP, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of MEDP, evaluating the profitability, health, valuation and growth aspects
- MEDPACE HOLDINGS INC (MEDP) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- MEDPACE HOLDINGS INC (MEDP) Sales and EPS estimates to see what analysts future expectations are.
- MEDPACE HOLDINGS INC (MEDP) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- MEDPACE HOLDINGS INC (MEDP) Insider and Institutional Ownership to learn about the owners and their transactions.
- MEDPACE HOLDINGS INC (MEDP) Stock Chart to make your own analysis
- MEDPACE HOLDINGS INC (MEDP) Latest news and press-releases to stay up to date.
Does MEDPACE HOLDINGS INC (MEDP) stock pay dividends?
MEDP does not pay a dividend.
When does MEDPACE HOLDINGS INC (MEDP) report earnings?
MEDPACE HOLDINGS INC (MEDP) will report earnings on 2025-10-20, after the market close.
What is the Price/Earnings (PE) ratio of MEDPACE HOLDINGS INC (MEDP)?
The PE ratio for MEDPACE HOLDINGS INC (MEDP) is 36.48. This is based on the reported non-GAAP earnings per share of 13.45 and the current share price of 490.64 USD. Check the full fundamental report for a full analysis of the valuation metrics for MEDP.
What is the Short Interest ratio of MEDPACE HOLDINGS INC (MEDP) stock?
The outstanding short interest for MEDPACE HOLDINGS INC (MEDP) is 10.26% of its float. Check the ownership tab for more information on the MEDP short interest.
MEDP Technical Analysis
ChartMill assigns a technical rating of 9 / 10 to MEDP. When comparing the yearly performance of all stocks, MEDP is one of the better performing stocks in the market, outperforming 91.55% of all stocks.
MEDP Fundamental Analysis
ChartMill assigns a fundamental rating of 7 / 10 to MEDP. Both the health and profitability get an excellent rating, making MEDP a very profitable company, without any liquidiy or solvency issues.
MEDP Financial Highlights
Over the last trailing twelve months MEDP reported a non-GAAP Earnings per Share(EPS) of 13.45. The EPS increased by 26.53% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 18.74% | ||
| ROA | 26.61% | ||
| ROE | 242.7% | ||
| Debt/Equity | 0 |
MEDP Forecast & Estimates
17 analysts have analysed MEDP and the average price target is 433.33 USD. This implies a price decrease of -11.68% is expected in the next year compared to the current price of 490.64.
For the next year, analysts expect an EPS growth of 13.45% and a revenue growth 16.85% for MEDP